Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Michael Addition . These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Novel 3-step route for Pregabalin avoids resolution waste. High ee value up to 99.6%. Cost-effective manufacturing for pharma intermediates.
Patent CN113831357A discloses a Lewis acid-catalyzed Michael addition for imidazothiazoles, offering mild conditions and high functional group tolerance for pharmaceutical manufacturing.
Discover advanced synthesis for imidazo[1,2-a]pyridine intermediates via Lewis acid catalysis. Enhance supply chain reliability and reduce manufacturing costs with scalable protocols.
Patent CN108822101B reveals a high-yield Michael addition route for benzhydryl quinuclidinone, offering cost reduction and scalable production for veterinary APIs.
Novel synthesis route for hexahydropyridine-indolone scaffolds offers improved yields and stability. Ideal for scalable pharmaceutical intermediate production and cost-effective supply chain integration globally.
Efficient asymmetric Michael addition for pharmaceutical intermediates using novel Ru-diamine complexes. Reduces cost and improves purity for API manufacturing.
Patent CN117659079A reveals a mild synthesis route for glufosinate intermediates. Achieve cost reduction in agrochemical intermediate manufacturing with scalable technology.
Patent CN104262290B reveals high-yield pridinol mesylate synthesis. Optimized Grignard route ensures cost reduction and supply chain reliability for global buyers.
Patent CN101851182A reveals a salt-free route for substituted taurine. Discover cost-effective manufacturing and high-purity supply chain solutions for global pharma.
Patent CN105985292B enables mild asymmetric catalysis. Delivers high-purity pharmaceutical intermediates with substantial cost reduction and supply chain reliability.
Patent CN106674179B reveals a mild, metal-free route to novel 6'-aminoluteolin derivatives. Discover cost-effective manufacturing strategies for next-generation NSAID intermediates.
Patent CN110028422B reveals a reversible Michael addition method for amino protection using imidazole hydrochloride, offering cost-effective and scalable solutions for pharmaceutical intermediate manufacturing.
Patent CN101570524B reveals a novel route for substituted andrographolide derivatives with superior anti-tumor activity and simplified manufacturing processes.
Patent CN102180886B details a novel enantioselective route to Galanthamine using organocatalysis, offering high purity and scalable manufacturing for pharmaceutical supply chains.
Novel alkaline hydrolysis route for azelastine intermediate improves yield to 65.9% and reduces environmental impact for reliable supply.
Patent CN109970753B details organocatalytic synthesis of xanthone-oxindole hybrids. Offers high stereoselectivity and anti-tumor potential for drug discovery.
Patent CN107312010A reveals a high-yield sitagliptin synthesis route. Offers cost reduction and supply chain reliability for pharmaceutical manufacturers.
Novel synthesis route for GABA derivative intermediates featuring high purity and mild conditions. Enables cost-effective manufacturing for global pharmaceutical supply chains.
Patent CN107987000B enables high-purity β-mercaptan carboxylic acid production with stable solid base catalysts, ensuring cost reduction and supply chain reliability for global buyers.
Patent CN100584459C reveals a novel metal-free organocatalyst enabling dual-handed synthesis of gamma-nitro ketones with >99% ee, offering significant cost reduction and supply chain reliability.